วัคซีนใหม่ล่าสุดในการป้องกันไวรัสตับอักเสบชนิดอี (Hepatitis E Vaccine; HEV 239 Hecolin®)
Article Sidebar
Published:
Sep 9, 2024
Main Article Content
Article Details
How to Cite
เหลืองจารุ ส. (2024). วัคซีนใหม่ล่าสุดในการป้องกันไวรัสตับอักเสบชนิดอี (Hepatitis E Vaccine; HEV 239 Hecolin®). Maharat Nakhon Ratchasima Hospital Journal, 35(2), 85–86. Retrieved from https://he04.tci-thaijo.org/index.php/MNRHJ/article/view/1737
Section
Editorial
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Aggarwal R. Hepatitis E: Historical, contemporary and future perspectives. J Gastroenterol Hepatol 2011; 26: S72-S82.
Kamili S. Toward the development of a hepatitis E vaccine. Virus Res 2011; 161:93-100.
Zhu FC, Zhang J, Zhang XF, Zhou C, Wang ZZ, Huang SJ, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 2010;376:895-902.
Wu T, Zhu FC, Huang SJ, Zhang XF, Wang ZZ, Zhang J, et al. Safety of the hepatitis E vaccine for pregnant women: A preliminary analysis. Hepatology 2012; 55: 2038-45.